Yinfeng Biological Group., Ltd always regards technological innovation as lifeblood of the strategic development, insists on the combination of independent R&D and scientific research cooperation, introduces and trains high-level technological talents, and positively establishes cooperation relationship with domestic famous scientific research institutions, so it has achieved the advanced technologies of neural stem-cell treatment on spinal cord injury and brain injury, new drug R&D of oligodendrocyte precursor cell, new drug R&D of stem-cell factor and inducing human iPS through CD47 inhibition. Yinfeng Biological Group., Ltd has the most authoritative team of experts and scholars in the industry, which respectively come from different fields of oncology, immunology, hematology, cryomedical sciences, and regenerative medicine.